131 related articles for article (PubMed ID: 23059548)
1. Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion.
Zhu Z; Li R; Xiao G; Chen Z; Yang J; Zhu Q; Liu S
Eur J Med Chem; 2012 Nov; 57():211-6. PubMed ID: 23059548
[TBL] [Abstract][Full Text] [Related]
2. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.
Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B
Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025
[TBL] [Abstract][Full Text] [Related]
3. Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell.
Zhu Z; Yao Z; Shen X; Chen Z; Liu X; Parquette JR; Liu S
Eur J Med Chem; 2017 Apr; 130():185-194. PubMed ID: 28246043
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of saponin derivatives: a series of entry inhibitors for highly pathogenic H5N1 influenza virus.
Ding N; Chen Q; Zhang W; Ren S; Guo Y; Li Y
Eur J Med Chem; 2012 Jul; 53():316-26. PubMed ID: 22575533
[TBL] [Abstract][Full Text] [Related]
5. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.
de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S
Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685
[TBL] [Abstract][Full Text] [Related]
6. Study on the Antiviral Activities and Hemagglutinin-Based Molecular Mechanism of Novel Chlorogenin 3-
Shi WZ; Jiang LZ; Song GP; Wang S; Xiong P; Ke CW
Viruses; 2020 Mar; 12(3):. PubMed ID: 32168921
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus.
Li H; Chen L; Li S; Liao Y; Wang L; Liu Z; Liu S; Song G
Bioorg Med Chem Lett; 2019 Sep; 29(18):2675-2680. PubMed ID: 31371135
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors.
Song G; Shen X; Li S; Li Y; Si H; Fan J; Li J; Gao E; Liu S
Eur J Med Chem; 2016 Aug; 119():109-21. PubMed ID: 27153348
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of 3-O-β-chacotriosyl ursolic acid derivatives as novel H5N1 entry inhibitors.
Song G; Shen X; Li S; Li Y; Liu Y; Zheng Y; Lin R; Fan J; Ye H; Liu S
Eur J Med Chem; 2015 Mar; 93():431-42. PubMed ID: 25728024
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening.
Zhang J; Liu T; Tong X; Li G; Yan J; Ye X
Antiviral Res; 2012 Jan; 93(1):48-54. PubMed ID: 22057306
[TBL] [Abstract][Full Text] [Related]
12. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
[TBL] [Abstract][Full Text] [Related]
13. An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
Li R; Song D; Zhu Z; Xu H; Liu S
PLoS One; 2012; 7(8):e41956. PubMed ID: 22876294
[TBL] [Abstract][Full Text] [Related]
14. Discovery of the first series of small molecule H5N1 entry inhibitors.
Song G; Yang S; Zhang W; Cao Y; Wang P; Ding N; Zhang Z; Guo Y; Li Y
J Med Chem; 2009 Dec; 52(23):7368-71. PubMed ID: 19537689
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus.
Li S; Jia X; Shen X; Wei Z; Jiang Z; Liao Y; Guo Y; Zheng X; Zhong G; Song G
Bioorg Med Chem; 2017 Aug; 25(16):4384-4396. PubMed ID: 28651913
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H(5)N(1).
Yang J; Yang JX; Zhang F; Chen G; Pan W; Yu R; Wu S; Tien P
Bioorg Med Chem Lett; 2014 Jun; 24(12):2680-4. PubMed ID: 24803363
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory activities of 3-trifluoromethyl benzamide derivatives against the entry of H5N1 influenza viruses].
Zhu Z; Cai Y; Yang J; Li X; Li R; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):961-4. PubMed ID: 25057064
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism.
Yang J; Chen G; Li LL; Pan W; Zhang F; Yang J; Wu S; Tien P
Bioorg Med Chem Lett; 2013 May; 23(9):2619-23. PubMed ID: 23538114
[TBL] [Abstract][Full Text] [Related]
19. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
Chen X; Si L; Liu D; Proksch P; Zhang L; Zhou D; Lin W
Eur J Med Chem; 2015 Mar; 93():182-95. PubMed ID: 25681711
[TBL] [Abstract][Full Text] [Related]
20. synthesis and preliminary biologic evaluation of 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles as a novel class of influenza virus A inhibitors.
Li Z; Zhan P; Naesens L; Vanderlinden E; Liu A; Du G; De Clercq E; Liu X
Chem Biol Drug Des; 2012 Jun; 79(6):1018-24. PubMed ID: 22284752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
